Company / Cash per Share
NOVAVAX INC Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.50
FY2025
5-year range
$1.50 / $21.35
FY2021-FY2025
Trend
-60.5%
vs FY2024
Sector context
#126 of 205
Health Care
What the data says
At $1.50, NOVAVAX INC's cash per share ranks #126 of 205 in the Health Care sector. Cash per Share has declined for 4 consecutive years, from $21.35 in FY2021 to $1.50 in FY2025.
Based on SEC 10-K filings.
1.50 in FY2025 with a 5-year CAGR of -38.5%.
Declined from $6.61 to $1.50 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -57.8%
- 5-Year CAGR
- -38.5%
- 10-Year CAGR
- -
Sector benchmark
#126 of 205 in Health CareTop 61% of 205This company $1.50 Sector average $67.98
▼
-97.8% below sector average
Key checks
Key Insights
- NOVAVAX INC's cash per share has declined for 4 consecutive years.
- In FY2025, cash per share decreased 60.5% year-over-year.
- Ranks #126 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.50 | -60.5% |
| FY2024 | $3.80 | -42.5% |
| FY2023 | $6.61 | -66.9% |
| FY2022 | $19.98 | -6.4% |
| FY2021 | $21.35 | +24.8% |
| FY2020 | $17.11 | +317.1% |
| FY2019 | $4.10 | +1789.3% |
| FY2018 | $0.22 | -44.6% |
| FY2017 | $0.39 | +227.2% |
| FY2016 | $0.12 | -76.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026